Flowsion ApS is developing an intravenous sensor specifically for tight glycemic control (TGC) in the critical care market. Our device (the Diramo System) is intended to continuously measure, record and track the blood glucose level (BGL) in critically ill patients (i.e., those patients under intensive-care treatment within an ICU) and to provide appropriate alarms in case of hypo- and hyperglycemic readings by the device.
